Lorbrena (lorlatinib) — NDC 0069-0227 by Pfizer Laboratories Div Pfizer Inc
Lorbrena (lorlatinib) — NDC 0069-0227 by Pfizer Laboratories Div Pfizer Inc is one of 9,000 drug products in the NDCLookup dataset. Key details — Brand name: Lorbrena; Generic name: lorlatinib; Product NDC: 0069-0227.
| Brand name | Lorbrena |
|---|---|
| Generic name | lorlatinib |
| Product NDC | 0069-0227 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Active ingredients | LORLATINIB 25 mg/1 |
| Pharmacologic class | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA], Multidrug and Toxin Extrusion |
| Marketing category | NDA |
| Product type | HUMAN PRESCRIPTION DRUG |
| Source | openFDA NDC Directory |
$899/mo
Try NDCLookup →